Viridian Capital Advisors

The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and...

The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and...

Since the beginning of the legal cannabis industry, the vast majority of investors in the space have been high-net-worth individuals and family offices. These groups were more able to make these investments given they were not beholden to the same restrictions or foci as more institutional players...

The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and...

Tilray Inc (NASDAQ: TLRY) dominated news in the cannabis sector this week after its stock went on a wild rollercoaster ride. Even talk about The Coca-Cola Co (NYSE: KO) exploring entry into the marijuana industry took a back seat to the action in Tilray’s shares. The company’s...

Money is flowing into the cannabis industry at an unprecedented pace. And it’s not just the Canopy Growth Corp (NYSE: CGC) and Cronos Group Inc (NASDAQ: CRON)’s of the world on the receiving end: public and private companies across the spectrum are drawing ...

A four-day week shortened by Labor Day still brought substantial news in the cannabis sector.  “Even though this week was a shortened trading week, there were still lots of financial deals happening. Cronos Group agreed to a partnership with Gingko Bioworks that could be worth $122...

Canadian cannabis producer Tilray commenced trading on the Nasdaq this week, becoming the first pure-play marijuana company to list on a major U.S. stock exchange. “This week's listing of Tilray on NASDAQ is another positive move for cannabis stocks and particularly for the U.S....

Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Space is limited—get your tickets before they sell out. Ahead of the...

This was a very active week in the cannabis capital markets, with Cronos Group reporting earnings, Canopy Growth applying to trade on the NYSE, Aurora Cannabis acquiring MedReleaf in the largest cannabis deal in history and GTI announcing intentions to go public in Canada. The news drove the United...

Almost every week, an American or Canadian cannabis company announces a large overseas investment. And it's no longer just Germany, Israel and Australia that are piquing investors’ interest. Emerging markets like Jamaica are also turning heads. The largest investment opportunities might...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...

January was a great month for the cannabis industry, despite Attorney General Jeff Sessions’ decision to rescind the Cole Memo, an Obama-era memorandum that essentially protected state-legal cannabis businesses from federal prosecution. Marijuana companies received more than $1.2 billion in...

Interest in who is investing in the marijuana industry is mounting rapidly, and not without a reason. Over the first five weeks of 2018, the Viridian Cannabis Deal Tracker registered $1.23 billion in investments in the cannabis industry, Viridian Capital President Scott Greiper told Benzinga....

Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry. As more institutional investors...